General Information of Drug (ID: DMO10JI)

Drug Name
HibTITER Drug Info
Synonyms Haemophilus vaccine II, Praxis; Conjugate vaccine (Haemophilus influenzae type B/ meningitis), Nuron Biotech
Indication
Disease Entry ICD 11 Status REF
Pneumococcal infection CA00-CA40 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMO10JI

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NU300 DMO0C5R Influenza virus infection 1E30-1E32 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Haemophilus influenzae CRM197 (Hae-influ CRM197) TTC6JZQ NOUNIPROTAC Not Available [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011380)
2 Immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infants. J Microbiol Immunol Infect. 1998 Sep;31(3):180-6.
3 ClinicalTrials.gov (NCT02140047) Exploratory Clinical Study of MT-2301. U.S. National Institutes of Health.